EMA Deciding If Donanemab For Alzheimer’s & Three Other Drugs Merit Fast-Tracking

 
• By Neena Brizmohun
  
Alzheimer's puzzle
Lilly's donanemab is designed to slow Alzheimer’s disease progression • Source: Shutterstock

More from Europe

More from Geography